Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole-based regimens for Loa loa microfilaremia reduction in Gabon
PACTR201807197019027Phase 2Completed
- Sponsor
- Ayola Akim Adegnika
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of albendazole and ivermectin in loiasis (4 arms), sponsored by Ayola Akim Adegnika. Started Feb 2018; status: completed.
02
Drugs
albendazoleivermectin
03
Conditions
loiasis
Beyond the preview
Go deeper on PACTR201807197019027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201807197019027.